116 related articles for article (PubMed ID: 3023535)
1. Restoration of wild-type pathogenicity to an attenuated DNA polymerase mutant of herpes simplex virus type 1.
Larder BA; Lisle JJ; Darby G
J Gen Virol; 1986 Nov; 67 ( Pt 11)():2501-6. PubMed ID: 3023535
[TBL] [Abstract][Full Text] [Related]
2. Cooperative effects between two acyclovir resistance loci in herpes simplex virus.
Darby G; Churcher MJ; Larder BA
J Virol; 1984 Jun; 50(3):838-46. PubMed ID: 6328014
[TBL] [Abstract][Full Text] [Related]
3. Properties of purified enzymes induced by pathogenic drug-resistant mutants of herpes simplex virus. Evidence for virus variants expressing normal DNA polymerase and altered thymidine kinase.
Larder BA; Derse D; Cheng YC; Darby G
J Biol Chem; 1983 Feb; 258(3):2027-33. PubMed ID: 6296119
[TBL] [Abstract][Full Text] [Related]
4. Pathogenicity of herpes simplex virus mutants containing drug resistance mutations in the viral DNA polymerase gene.
Field HJ; Coen DM
J Virol; 1986 Oct; 60(1):286-9. PubMed ID: 3018291
[TBL] [Abstract][Full Text] [Related]
5. Resistance to antiviral inhibitors caused by the mutation S889A in the highly-conserved 885-GDTDS motif of the herpes simplex virus type 1 DNA polymerase.
Dorsky DI; Plourde C
Virology; 1993 Aug; 195(2):831-5. PubMed ID: 8337848
[TBL] [Abstract][Full Text] [Related]
6. Neurovirulence and latency of drug-resistant clinical herpes simplex viruses in animal models.
Dambrosi S; Martin M; Yim K; Miles B; Canas J; Sergerie Y; Boivin G
J Med Virol; 2010 May; 82(6):1000-6. PubMed ID: 20419814
[TBL] [Abstract][Full Text] [Related]
7. Single nucleotide polymorphisms of thymidine kinase and DNA polymerase genes in clinical herpes simplex virus type 1 isolates associated with different resistance phenotypes.
Schubert A; Gentner E; Bohn K; Schwarz M; Mertens T; Sauerbrei A
Antiviral Res; 2014 Jul; 107():16-22. PubMed ID: 24747042
[TBL] [Abstract][Full Text] [Related]
8. Selection and characterisation of acyclovir-resistant herpes simplex virus type 1 mutants inducing altered DNA polymerase activities.
Larder BA; Darby G
Virology; 1985 Oct; 146(2):262-71. PubMed ID: 2996220
[TBL] [Abstract][Full Text] [Related]
9. Slipping and sliding: frameshift mutations in herpes simplex virus thymidine kinase and drug-resistance.
Griffiths A
Drug Resist Updat; 2011 Dec; 14(6):251-9. PubMed ID: 21940196
[TBL] [Abstract][Full Text] [Related]
10. Resistance of herpes simplex virus to acycloguanosine--genetic and physical analysis.
Crumpacker CS; Chartrand P; Subak-Sharpe JH; Wilkie NM
Virology; 1980 Aug; 105(1):171-84. PubMed ID: 6251603
[No Abstract] [Full Text] [Related]
11. Single mutations at many sites within the DNA polymerase locus of herpes simplex viruses can confer hypersensitivity to aphidicolin and resistance to phosphonoacetic acid.
Honess RW; Purifoy DJ; Young D; Gopal R; Cammack N; O'Hare P
J Gen Virol; 1984 Jan; 65 ( Pt 1)():1-17. PubMed ID: 6319564
[TBL] [Abstract][Full Text] [Related]
12. Mutations within conserved motifs in the 3'-5' exonuclease domain of herpes simplex virus DNA polymerase.
Hall JD; Orth KL; Sander KL; Swihart BM; Senese RA
J Gen Virol; 1995 Dec; 76 ( Pt 12)():2999-3008. PubMed ID: 8847505
[TBL] [Abstract][Full Text] [Related]
13. DNA polymerase mutations in drug-resistant herpes simplex virus mutants determine in vivo neurovirulence and drug-enzyme interactions.
Andrei G; Fiten P; Froeyen M; De Clercq E; Opdenakker G; Snoeck R
Antivir Ther; 2007; 12(5):719-32. PubMed ID: 17713155
[TBL] [Abstract][Full Text] [Related]
14. Reversion of mutations in the thymidine kinase gene in herpes simplex viruses resistant to phosphonoacetate.
Campione-Piccardo J; Rawls WE
Can J Microbiol; 1984 May; 30(5):560-4. PubMed ID: 6331620
[TBL] [Abstract][Full Text] [Related]
15. The herpes simplex virus type 1 DNA polymerase gene: site of phosphonoacetic acid resistance mutation in strain Angelotti is highly conserved.
Knopf CW
J Gen Virol; 1987 May; 68 ( Pt 5)():1429-33. PubMed ID: 3033142
[TBL] [Abstract][Full Text] [Related]
16. Aphidicolin resistance in herpes simplex virus type 1 appears to alter substrate specificity in the DNA polymerase.
Hall JD; Woodward S
J Virol; 1989 Jun; 63(6):2874-6. PubMed ID: 2542598
[TBL] [Abstract][Full Text] [Related]
17. Progressive esophagitis from acyclovir-resistant herpes simplex. Clinical roles for DNA polymerase mutants and viral heterogeneity?
Sacks SL; Wanklin RJ; Reece DE; Hicks KA; Tyler KL; Coen DM
Ann Intern Med; 1989 Dec; 111(11):893-9. PubMed ID: 2554768
[TBL] [Abstract][Full Text] [Related]
18. Isolation and characterisation of herpes simplex virus type 1 mutants which fail to induce dUTPase activity.
Fisher FB; Preston VG
Virology; 1986 Jan; 148(1):190-7. PubMed ID: 3002029
[TBL] [Abstract][Full Text] [Related]
19. Thymidine kinase deletion mutants of herpes simplex virus type 1.
Sanders PG; Wilkie NM; Davison AJ
J Gen Virol; 1982 Dec; 63(2):277-95. PubMed ID: 6296278
[TBL] [Abstract][Full Text] [Related]
20. Mutations in the Exo III motif of the herpes simplex virus DNA polymerase gene can confer altered drug sensitivities.
Hwang YT; Smith JF; Gao L; Hwang CB
Virology; 1998 Jul; 246(2):298-305. PubMed ID: 9657948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
